Jessica A. Cooley Coleman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jessica A. Cooley Coleman has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Steven A. Skinner
Greenwood Genetic Center, Greenwood, USA
4 shared publicationsFran Annese
Greenwood Genetic Center, Greenwood, USA
3 shared publications- Luigi Boccuto
Healthcare Genetics and Genomics Program, School of Nursing, Clemson University, Clemson, SC 29634, USA
3 shared publications - Steven A. Skinner
Greenwood Genetic Center, Greenwood, USA
3 shared publications Adalia Zhou
Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, USA
2 shared publicationsAjit S. Divakaruni
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, USA
2 shared publications
Latest Publications
- 25 November 2025
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 34 (1) , 53-60
Identification of an episignature for the MEF2C-associated syndrome
Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language (NEDHSIL), also known as MEF2C-related disorder or MEF2C haploinsufficiency syndrome (MCHS), is a condition caused by pathogenic variants in the Myocyte Enhancer Factor-2C (MEF2C) gene. This study aimed to identify a DNA methylation episignature specific to NEDHSIL and explore its similarities with other known episignatures. Genome-wide DNA levels were assessed in a cohort of patients with MEF2C mutations and controls, and differentially methylated CpG sites were identified. A bioinformatic analysis yielded a classifier that was trained against controls and other known episignature disorders within the EpiSign Knowledge Database. The classifier demonstrated high accuracy, sensitivity, and specificity in classifying NEDHSIL samples. Furthermore, functional annotation and comparative analysis revealed similarities between the NEDHSIL episignature and other genetic neurodevelopmental disorders. This study provides evidence for a DNA methylation episignature specific to NEDHSIL and highlights the potential utility of this epigenetic biomarker for diagnosing and understanding molecular pathophysiology of neurodevelopmental disorders associated with MEF2C mutations.
- 25 November 2025
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 34 (1) , 53-60
Identification of an episignature for the MEF2C-associated syndrome
Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language (NEDHSIL), also known as MEF2C-related disorder or MEF2C haploinsufficiency syndrome (MCHS), is a condition caused by pathogenic variants in the Myocyte Enhancer Factor-2C (MEF2C) gene. This study aimed to identify a DNA methylation episignature specific to NEDHSIL and explore its similarities with other known episignatures. Genome-wide DNA levels were assessed in a cohort of patients with MEF2C mutations and controls, and differentially methylated CpG sites were identified. A bioinformatic analysis yielded a classifier that was trained against controls and other known episignature disorders within the EpiSign Knowledge Database. The classifier demonstrated high accuracy, sensitivity, and specificity in classifying NEDHSIL samples. Furthermore, functional annotation and comparative analysis revealed similarities between the NEDHSIL episignature and other genetic neurodevelopmental disorders. This study provides evidence for a DNA methylation episignature specific to NEDHSIL and highlights the potential utility of this epigenetic biomarker for diagnosing and understanding molecular pathophysiology of neurodevelopmental disorders associated with MEF2C mutations.
- 31 May 2025
- Published by Springer Nature in Journal of Community Genetics
- Vol. 16 (5) , 569-580
Call for neurofibromatosis specialty care clinics in South Carolina
Grounded in patient input, this study assesses the perceived need for a dedicated multidisciplinary clinic for individuals and families with neurofibromatosis type 1 (NF1) in South Carolina, USA. A 62-question online cross-sectional survey, available in English and Spanish, was distributed to South Carolina residents over age 18 years who were either adults who do not have NF1 but have children with NF1, adults with NF1 who have children with NF1, and adults with NF1 who do not have children or may have children without NF1, to capture a wide range of experiences. Survey responses were analyzed using descriptive statistics to summarize key findings and chi-squared and Fisher’s exact tests for categorical comparisons. Free-text responses were examined by content analysis and evaluated by a second researcher. A total of 52 survey responses were analyzed. 90.4% indicated that a specialty clinic should exist in South Carolina. More than 70% of participants reported adherence to medical advice for NF1 and saw a doctor at least once per year, with children and adults seeing several relevant specialists. Analysis of free text responses revealed that participants perceive limited resources and awareness for NF1 in South Carolina, with 4 key gaps identified in both education and clinical care. Establishing a dedicated, multidisciplinary care center for individuals with NF1 in South Carolina can address 3 out of the 4 clinical care gaps and 1 out of the 4 education gaps identified by the content analysis and is highly supported by participant preference.
- 31 May 2025
- Published by Springer Nature in Journal of Community Genetics
- Vol. 16 (5) , 569-580
Call for neurofibromatosis specialty care clinics in South Carolina
Grounded in patient input, this study assesses the perceived need for a dedicated multidisciplinary clinic for individuals and families with neurofibromatosis type 1 (NF1) in South Carolina, USA. A 62-question online cross-sectional survey, available in English and Spanish, was distributed to South Carolina residents over age 18 years who were either adults who do not have NF1 but have children with NF1, adults with NF1 who have children with NF1, and adults with NF1 who do not have children or may have children without NF1, to capture a wide range of experiences. Survey responses were analyzed using descriptive statistics to summarize key findings and chi-squared and Fisher’s exact tests for categorical comparisons. Free-text responses were examined by content analysis and evaluated by a second researcher. A total of 52 survey responses were analyzed. 90.4% indicated that a specialty clinic should exist in South Carolina. More than 70% of participants reported adherence to medical advice for NF1 and saw a doctor at least once per year, with children and adults seeing several relevant specialists. Analysis of free text responses revealed that participants perceive limited resources and awareness for NF1 in South Carolina, with 4 key gaps identified in both education and clinical care. Establishing a dedicated, multidisciplinary care center for individuals with NF1 in South Carolina can address 3 out of the 4 clinical care gaps and 1 out of the 4 education gaps identified by the content analysis and is highly supported by participant preference.
- Open Access
- 19 April 2024
- Published by Springer Nature in Nature Immunology
- Vol. 25 (5) , 928
Author Correction: MEF2C regulates NK cell effector functions through control of lipid metabolism
- 19 April 2024
- Published by Springer Nature in Nature Immunology
- Vol. 25 (5) , 928
Open AccessAuthor Correction: MEF2C regulates NK cell effector functions through control of lipid metabolism
- 8 April 2024
- Published by Springer Nature in Nature Immunology
- Vol. 25 (5) , 778-789
MEF2C regulates NK cell effector functions through control of lipid metabolism
Natural killer (NK) cells are a critical first line of defense against viral infection. Rare mutations in a small subset of transcription factors can result in decreased NK cell numbers and function in humans, with an associated increased susceptibility to viral infection. However, our understanding of the specific transcription factors governing mature human NK cell function is limited. Here we use a non-viral CRISPR–Cas9 knockout screen targeting genes encoding 31 transcription factors differentially expressed during human NK cell development. We identify myocyte enhancer factor 2C (MEF2C) as a master regulator of human NK cell functionality ex vivo. MEF2C-haploinsufficient patients and mice displayed defects in NK cell development and effector function, with an increased susceptibility to viral infection. Mechanistically, MEF2C was required for an interleukin (IL)-2- and IL-15-mediated increase in lipid content through regulation of sterol regulatory element-binding protein (SREBP) pathways. Supplementation with oleic acid restored MEF2C-deficient and MEF2C-haploinsufficient patient NK cell cytotoxic function. Therefore, MEF2C is a critical orchestrator of NK cell antiviral immunity by regulating SREBP-mediated lipid metabolism.
- 8 April 2024
- Published by Springer Nature in Nature Immunology
- Vol. 25 (5) , 778-789
MEF2C regulates NK cell effector functions through control of lipid metabolism
Natural killer (NK) cells are a critical first line of defense against viral infection. Rare mutations in a small subset of transcription factors can result in decreased NK cell numbers and function in humans, with an associated increased susceptibility to viral infection. However, our understanding of the specific transcription factors governing mature human NK cell function is limited. Here we use a non-viral CRISPR–Cas9 knockout screen targeting genes encoding 31 transcription factors differentially expressed during human NK cell development. We identify myocyte enhancer factor 2C (MEF2C) as a master regulator of human NK cell functionality ex vivo. MEF2C-haploinsufficient patients and mice displayed defects in NK cell development and effector function, with an increased susceptibility to viral infection. Mechanistically, MEF2C was required for an interleukin (IL)-2- and IL-15-mediated increase in lipid content through regulation of sterol regulatory element-binding protein (SREBP) pathways. Supplementation with oleic acid restored MEF2C-deficient and MEF2C-haploinsufficient patient NK cell cytotoxic function. Therefore, MEF2C is a critical orchestrator of NK cell antiviral immunity by regulating SREBP-mediated lipid metabolism.
- 2 December 2022
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 32 (9) , 1457-1465
Clinical and functional characterization of germline PIK3CA variants in patients with PIK3CA-related overgrowth spectrum disorders
Mosaic variants in the PIK3CA gene, encoding the catalytic subunit of phosphatidylinositol 3-kinase (PI3K), produce constitutive PI3K activation which causes PIK3CA-related overgrowth spectrum (PROS) disorders. To date, fewer than 20 patients have been described with germline alterations in PIK3CA. In this study, we describe three unrelated individuals with overgrowth and germline PIK3CA variants. These variants were discovered through whole-exome sequencing and confirmed as germline by testing multiple tissue types, when available. Functional analysis using Patient 1’s fibroblast cell line and two previously reported patients’ cell lines showed increased phosphorylation of AKT during cellular starvation revealing constitutive activation of the PI3K/AKT/mTOR pathway. Alternatively, stimulation of the cells by fetal bovine serum produced a reduced response, indicating an activated status of the PI3K complex reducing the pathway response to further external stimulation. Additional studies utilizing Biolog Phenotype Microarray technology indicated reduced energy production when cells were exposed to growth factors stimulating the PI3K/AKT/mTOR pathway, confirming the trend observed in the AKT phosphorylation test after stimulation. Furthermore, treatment with inhibitors of the PI3K/AKT/mTOR pathway rescued the normal energy response in the patients’ cells. Collectively, these data demonstrate that disease-causing germline PIK3CA variants have a functional consequence, similar to mosaic variants in the PI3K/AKT/mTOR pathway.
- 2 December 2022
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 32 (9) , 1457-1465
Clinical and functional characterization of germline PIK3CA variants in patients with PIK3CA-related overgrowth spectrum disorders
Mosaic variants in the PIK3CA gene, encoding the catalytic subunit of phosphatidylinositol 3-kinase (PI3K), produce constitutive PI3K activation which causes PIK3CA-related overgrowth spectrum (PROS) disorders. To date, fewer than 20 patients have been described with germline alterations in PIK3CA. In this study, we describe three unrelated individuals with overgrowth and germline PIK3CA variants. These variants were discovered through whole-exome sequencing and confirmed as germline by testing multiple tissue types, when available. Functional analysis using Patient 1’s fibroblast cell line and two previously reported patients’ cell lines showed increased phosphorylation of AKT during cellular starvation revealing constitutive activation of the PI3K/AKT/mTOR pathway. Alternatively, stimulation of the cells by fetal bovine serum produced a reduced response, indicating an activated status of the PI3K complex reducing the pathway response to further external stimulation. Additional studies utilizing Biolog Phenotype Microarray technology indicated reduced energy production when cells were exposed to growth factors stimulating the PI3K/AKT/mTOR pathway, confirming the trend observed in the AKT phosphorylation test after stimulation. Furthermore, treatment with inhibitors of the PI3K/AKT/mTOR pathway rescued the normal energy response in the patients’ cells. Collectively, these data demonstrate that disease-causing germline PIK3CA variants have a functional consequence, similar to mosaic variants in the PI3K/AKT/mTOR pathway.
- 18 August 2022
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 32 (3) , 386-401
Expansion and mechanistic insights into de novo DEAF1 variants in DEAF1-associated neurodevelopmental disorders
De novo deleterious and heritable biallelic mutations in the DNA binding domain (DBD) of the transcription factor deformed epidermal autoregulatory factor 1 (DEAF1) result in a phenotypic spectrum of disorders termed DEAF1-associated neurodevelopmental disorders (DAND). RNA-sequencing using hippocampal RNA from mice with conditional deletion of Deaf1 in the central nervous system indicate that loss of Deaf1 activity results in the altered expression of genes involved in neuronal function, dendritic spine maintenance, development, and activity, with reduced dendritic spines in hippocampal regions. Since DEAF1 is not a dosage-sensitive gene, we assessed the dominant negative activity of previously identified de novo variants and a heritable recessive DEAF1 variant on selected DEAF1-regulated genes in 2 different cell models. While no altered gene expression was observed in cells over-expressing the recessive heritable variant, the gene expression profiles of cells over-expressing de novo variants resulted in similar gene expression changes as observed in CRISPR-Cas9-mediated DEAF1-deleted cells. Altered expression of DEAF1-regulated genes was rescued by exogenous expression of WT-DEAF1 but not by de novo variants in cells lacking endogenous DEAF1. De novo heterozygous variants within the DBD of DEAF1 were identified in 10 individuals with a phenotypic spectrum including autism spectrum disorder, developmental delays, sleep disturbance, high pain tolerance, and mild dysmorphic features. Functional assays demonstrate these variants alter DEAF1 transcriptional activity. Taken together, this study expands the clinical phenotypic spectrum of individuals with DAND, furthers our understanding of potential roles of DEAF1 on neuronal function, and demonstrates dominant negative activity of identified de novo variants.
- 18 August 2022
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 32 (3) , 386-401
Expansion and mechanistic insights into de novo DEAF1 variants in DEAF1-associated neurodevelopmental disorders
De novo deleterious and heritable biallelic mutations in the DNA binding domain (DBD) of the transcription factor deformed epidermal autoregulatory factor 1 (DEAF1) result in a phenotypic spectrum of disorders termed DEAF1-associated neurodevelopmental disorders (DAND). RNA-sequencing using hippocampal RNA from mice with conditional deletion of Deaf1 in the central nervous system indicate that loss of Deaf1 activity results in the altered expression of genes involved in neuronal function, dendritic spine maintenance, development, and activity, with reduced dendritic spines in hippocampal regions. Since DEAF1 is not a dosage-sensitive gene, we assessed the dominant negative activity of previously identified de novo variants and a heritable recessive DEAF1 variant on selected DEAF1-regulated genes in 2 different cell models. While no altered gene expression was observed in cells over-expressing the recessive heritable variant, the gene expression profiles of cells over-expressing de novo variants resulted in similar gene expression changes as observed in CRISPR-Cas9-mediated DEAF1-deleted cells. Altered expression of DEAF1-regulated genes was rescued by exogenous expression of WT-DEAF1 but not by de novo variants in cells lacking endogenous DEAF1. De novo heterozygous variants within the DBD of DEAF1 were identified in 10 individuals with a phenotypic spectrum including autism spectrum disorder, developmental delays, sleep disturbance, high pain tolerance, and mild dysmorphic features. Functional assays demonstrate these variants alter DEAF1 transcriptional activity. Taken together, this study expands the clinical phenotypic spectrum of individuals with DAND, furthers our understanding of potential roles of DEAF1 on neuronal function, and demonstrates dominant negative activity of identified de novo variants.
- 4 August 2022
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (10) , 2988-2998
Mosaicism of common pathogenic MECP2 variants identified in two males with a clinical diagnosis of Rett syndrome
Rett (RTT) syndrome, a neurodevelopmental disorder caused by pathogenic variation in the MECP2 gene, is characterized by developmental regression, loss of purposeful hand movements, stereotypic hand movements, abnormal gait, and loss of spoken language. Due to the X‐linked inheritance pattern, RTT is typically limited to females. Recent studies revealed somatic mosaicism in MECP2 in male patients with RTT‐like phenotypes. While detecting mosaic variation using Sanger sequencing is theoretically possible for mosaicism over ~15%–20%, several variables, including efficiency of PCR, background noise, and/or human error, contribute to a low detection rate using this technology. Mosaic variants in two males were detected by next generation sequencing (NGS; Case 1) and by Sanger re‐sequencing (Case 2). Both had targeted digital PCR (dPCR) to confirm the variants. In this report, we present two males with classic RTT syndrome in whom we identified pathogenic variation in the MECP2 gene in the mosaic state (c.730C > T (p.Gln244*) in Patient 1 and c.397C > T (p.Arg133Cys) in Patient 2). In addition, estimates and measures of mosaic variant fraction were surprisingly similar between Sanger sequencing, NGS, and dPCR. The mosaic state of these variants contributed to a lengthy diagnostic odyssey for these patients. While NGS and even Sanger sequencing may be viable methods of detecting mosaic variation in DNA or RNA samples, applying targeted dPCR to supplement these sequencing technologies would provide confirmation of somatic mosaicism and mosaic fraction.
- 4 August 2022
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (10) , 2988-2998
Mosaicism of common pathogenic MECP2 variants identified in two males with a clinical diagnosis of Rett syndrome
Rett (RTT) syndrome, a neurodevelopmental disorder caused by pathogenic variation in the MECP2 gene, is characterized by developmental regression, loss of purposeful hand movements, stereotypic hand movements, abnormal gait, and loss of spoken language. Due to the X‐linked inheritance pattern, RTT is typically limited to females. Recent studies revealed somatic mosaicism in MECP2 in male patients with RTT‐like phenotypes. While detecting mosaic variation using Sanger sequencing is theoretically possible for mosaicism over ~15%–20%, several variables, including efficiency of PCR, background noise, and/or human error, contribute to a low detection rate using this technology. Mosaic variants in two males were detected by next generation sequencing (NGS; Case 1) and by Sanger re‐sequencing (Case 2). Both had targeted digital PCR (dPCR) to confirm the variants. In this report, we present two males with classic RTT syndrome in whom we identified pathogenic variation in the MECP2 gene in the mosaic state (c.730C > T (p.Gln244*) in Patient 1 and c.397C > T (p.Arg133Cys) in Patient 2). In addition, estimates and measures of mosaic variant fraction were surprisingly similar between Sanger sequencing, NGS, and dPCR. The mosaic state of these variants contributed to a lengthy diagnostic odyssey for these patients. While NGS and even Sanger sequencing may be viable methods of detecting mosaic variation in DNA or RNA samples, applying targeted dPCR to supplement these sequencing technologies would provide confirmation of somatic mosaicism and mosaic fraction.
- Open Access
- 13 April 2022
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 10 (6) , e1919
Clinical findings from the landmark MEF2C‐related disorders natural history study
Introduction: MEF2C‐related disorders are characterized by developmental and cognitive delay, limited language and walking, hypotonia, and seizures. A recent systematic review identified 117 patients with MEF2C‐related disorders across 43 studies. Despite these reports, the disorder is not easily recognized and assessments are hampered by small sample sizes. Our objective was to gather developmental and clinical information on a large number of patients.Methods: We developed a survey based on validated instruments and subject area experts to gather information from parents of children with this condition. No personal identifiers were collected. Surveys and data were collected via REDCap and analyzed using Excel and SAS v9.4.Results: Seventy‐three parents completed the survey, with 39.7% reporting a MEF2C variant and 54.8% reporting a deletion involving MEF2C. Limited speech (82.1%), seizures (86.3%), bruxism (87.7%), repetitive movements (94.5%), and high pain tolerance (79.5%) were some of the prominent features. Patients with MEF2C variants were similarly affected as those with deletions. Female subjects showed higher verbal abilities.Conclusion: This is the largest natural history study to date and establishes a comprehensive review of developmental and clinical features for MEF2C‐related disorders. This data can help providers diagnose patients and form the basis for longitudinal or genotype–phenotype studies.
- 13 April 2022
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 10 (6) , e1919
Open AccessClinical findings from the landmark MEF2C‐related disorders natural history study
Introduction: MEF2C‐related disorders are characterized by developmental and cognitive delay, limited language and walking, hypotonia, and seizures. A recent systematic review identified 117 patients with MEF2C‐related disorders across 43 studies. Despite these reports, the disorder is not easily recognized and assessments are hampered by small sample sizes. Our objective was to gather developmental and clinical information on a large number of patients.Methods: We developed a survey based on validated instruments and subject area experts to gather information from parents of children with this condition. No personal identifiers were collected. Surveys and data were collected via REDCap and analyzed using Excel and SAS v9.4.Results: Seventy‐three parents completed the survey, with 39.7% reporting a MEF2C variant and 54.8% reporting a deletion involving MEF2C. Limited speech (82.1%), seizures (86.3%), bruxism (87.7%), repetitive movements (94.5%), and high pain tolerance (79.5%) were some of the prominent features. Patients with MEF2C variants were similarly affected as those with deletions. Female subjects showed higher verbal abilities.Conclusion: This is the largest natural history study to date and establishes a comprehensive review of developmental and clinical features for MEF2C‐related disorders. This data can help providers diagnose patients and form the basis for longitudinal or genotype–phenotype studies.
- 29 June 2021
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 185 (12) , 3884-3894
Comprehensive investigation of the phenotype of MEF2C‐related disorders in human patients: A systematic review
MEF2C‐related disorders (aka MEF2C‐haploinsufficiency) are caused by variations in or involving the MEF2C gene and are characterized by intellectual disability, developmental delay, lack of speech, limited walking, and seizures. Despite these findings, the disorder is not easily recognized clinically. We performed a systematic review following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines to assemble the most comprehensive list of patients and their phenotypes. Through searching PubMed, Web of Science, and MEDLINE, 43 articles met the inclusion criteria and were fully reviewed. One hundred and seventeen patients were identified from these publications with most having a phenotype of intellectual disability, developmental delay, seizures, hypotonia, absent speech, inability to walk, stereotypic movements, and MRI abnormalities. Nonclassical findings included one patient with a question mark ear, two patients with a jugular pit, one patient with a unique neuroendocrine finding, and nine patients that did not have MEF2C deletions or disruptions but may be affected due to a positional effect on MEF2C. This systematic review characterizes the phenotype of MEF2C‐related disorders, documents the severity of this condition, and will help providers to better diagnose and care for patients and their families. Additionally, this compiled information provides a comprehensive resource for investigators interested in pursuing specific genotype–phenotype correlations.
- 29 June 2021
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 185 (12) , 3884-3894
Comprehensive investigation of the phenotype of MEF2C‐related disorders in human patients: A systematic review
MEF2C‐related disorders (aka MEF2C‐haploinsufficiency) are caused by variations in or involving the MEF2C gene and are characterized by intellectual disability, developmental delay, lack of speech, limited walking, and seizures. Despite these findings, the disorder is not easily recognized clinically. We performed a systematic review following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines to assemble the most comprehensive list of patients and their phenotypes. Through searching PubMed, Web of Science, and MEDLINE, 43 articles met the inclusion criteria and were fully reviewed. One hundred and seventeen patients were identified from these publications with most having a phenotype of intellectual disability, developmental delay, seizures, hypotonia, absent speech, inability to walk, stereotypic movements, and MRI abnormalities. Nonclassical findings included one patient with a question mark ear, two patients with a jugular pit, one patient with a unique neuroendocrine finding, and nine patients that did not have MEF2C deletions or disruptions but may be affected due to a positional effect on MEF2C. This systematic review characterizes the phenotype of MEF2C‐related disorders, documents the severity of this condition, and will help providers to better diagnose and care for patients and their families. Additionally, this compiled information provides a comprehensive resource for investigators interested in pursuing specific genotype–phenotype correlations.
- Open Access
- 2 April 2021
- Published by Wiley in Nursing Open
- Vol. 8 (5) , 2419-2428
Tremors: A concept analysis
Aim: This article seeks to clarify and define the concept of tremors.Design: The Walker & Avant (2005) concept analysis method was followed.Methods: A search of PubMed, Academic Search Complete, CINAHL, ERIC, Google and Google Scholar was performed.Results: Through this process, uses of the concept were assessed including definitions and categories of tremors. Defining attributes were found to include “movement disorder,” “shaking motions,” “involuntary,” “oscillatory,” “rhythmic,” “not painful or life threatening,” “always present but variable” and “can sometimes be repressed.” We identified two model cases and a borderline case, antecedents, consequences and empirical referents (including measurement tools) of tremors.Conclusion: The concept analysis process has clarified and illuminated an operational definition of tremors: that tremors are a movement disorder characterized by shaking motions that are involuntary, oscillatory, rhythmic, non‐painful, always present although vary in severity, and can be repressed by changing posture or going into a rest position.
- 2 April 2021
- Published by Wiley in Nursing Open
- Vol. 8 (5) , 2419-2428
Open AccessTremors: A concept analysis
Aim: This article seeks to clarify and define the concept of tremors.Design: The Walker & Avant (2005) concept analysis method was followed.Methods: A search of PubMed, Academic Search Complete, CINAHL, ERIC, Google and Google Scholar was performed.Results: Through this process, uses of the concept were assessed including definitions and categories of tremors. Defining attributes were found to include “movement disorder,” “shaking motions,” “involuntary,” “oscillatory,” “rhythmic,” “not painful or life threatening,” “always present but variable” and “can sometimes be repressed.” We identified two model cases and a borderline case, antecedents, consequences and empirical referents (including measurement tools) of tremors.Conclusion: The concept analysis process has clarified and illuminated an operational definition of tremors: that tremors are a movement disorder characterized by shaking motions that are involuntary, oscillatory, rhythmic, non‐painful, always present although vary in severity, and can be repressed by changing posture or going into a rest position.